Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden · Delayed Price · Currency is SEK 0.1140
-0.0010 (-0.87%)
Aug 13, 2026, 1:56 PM CET
Spago Nanomedical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4.38 | 4.82 | 6.91 | 5.93 | 6.46 | 6.53 | |
Revenue Growth | -37.31% | -30.25% | 16.56% | -8.19% | -1.10% | -9.85% |
Gross Profit | 4.38 | 4.82 | 6.91 | 5.93 | 6.46 | 6.53 |
Selling, General & Admin | 18.39 | 19.65 | 25.71 | 23.67 | 24.84 | 23.53 |
Depreciation & Amortization Expenses | 0.12 | 0.17 | 0.31 | 0.28 | 0.36 | 0.38 |
Research & Development | 11.98 | 11.48 | 14.27 | 24.49 | 20.35 | 21.69 |
Other Operating Expenses | 0.28 | 0.47 | 0.33 | 0.57 | 0.38 | 0.13 |
Total Operating Expenses | 30.77 | 31.77 | 40.63 | 49 | 45.93 | 45.72 |
Operating Income | -26.39 | -26.94 | -33.71 | -43.07 | -39.47 | -39.19 |
Interest Income | - | 0.39 | 1.2 | 0.85 | 0.27 | 0.12 |
Total Non-Operating Income (Expense) | - | 0.39 | 1.2 | 0.85 | 0.27 | 0.12 |
Pretax Income | -25.92 | -26.55 | -32.51 | -42.22 | -39.2 | -39.07 |
Net Income | -25.92 | -26.55 | -32.51 | -42.22 | -39.2 | -39.07 |
Net Income to Common | -25.92 | -26.55 | -32.51 | -42.22 | -39.2 | -39.07 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 453 | 375 | 295 | 98 | 64 | 39 |
Shares Outstanding (Diluted) | 453 | 375 | 349 | 105 | 64 | 40 |
Shares Change | 29.83% | 7.25% | 232.99% | 63.55% | 60.54% | 44.10% |
EPS (Basic) | -0.06 | -0.07 | -0.11 | -0.43 | -0.67 | -1.10 |
EPS (Diluted) | -0.06 | -0.07 | -0.11 | -0.43 | -0.67 | -1.10 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -25.13 | -28.3 | -34.67 | -45.06 | -38.32 | -35.94 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.06 | -0.08 | -0.10 | -0.43 | -0.60 | -0.90 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -601.85% | -558.77% | -487.68% | -726.24% | -610.91% | -600.00% |
Profit Margin | -591.17% | -550.68% | -470.26% | -711.90% | -606.77% | -598.15% |
FCF Margin | -573.15% | -586.83% | -501.49% | -759.77% | -593.20% | -550.25% |
EBITDA | -26.39 | -26.94 | -33.71 | -43.07 | -39.47 | -39.19 |
EBIT | -26.39 | -26.94 | -33.71 | -43.07 | -39.47 | -39.19 |
EBIT Margin | -601.85% | -558.77% | -487.68% | -726.24% | -610.91% | -600.00% |